Oncolytics Biotech Inc T.ONC

New Press Release - THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS

Innovative Multimillion-Dollar Grant Was Created in 2022 to Drive Biopharma Industry to Speed Development of Pancreatic Cancer TherapiesBOSTON, SAN DIEGO, and CALGARY, AB, Sept. 26, 2023 /PRNewswire/ -- In an effort to continue accelerating new treatment options for people with pancreatic cancer,...read article.

[Lesalpes29]

Like somebody said, free money is good. 17M from the last PP + 5M = 22M! And if the price can reach well over 2.81 we will have an other 20M+ to work with... GLTAL 

[Quentin30]

A pity this isn't the actual Phase III, but a trial that 'could' lead to it... another wait... welcome, but also disappointing.

[Azzak34]

You just don't listen do you Quentin. There is a go/no-go period in the first part of the trial. They said this from the start. Pancan obviously aren't worried about the no-go part as they just gave us $5mill! More evidence that you are lost and dopey!! 

[Quentin30]

and what does good old market think of this news..... check out that enthusiastic price action, unless Matt has anything new to offer the pps will likely drop after his talk tomorrow... Heck you pumpers should love this, yet another chance after just 26 years to load up the steamboat... 5 million.... will keep the lights on for a month or so... this new release, is just more jam tomorrow news...

[Azzak34]

Hahahaha  Every time you have a dumb argument ridiculed you come back strong with a dumber one!! You are the best.  

[Noteable]

As I previously stated think the upcoming release of GOBLET data followed by the potential of Accelerated Approval with PanCan Precision Promise Phase 3 trial as the confirmatory trial that satisfies the FDA's post approval requirements.